Inventiva - ADR

NASDAQ:IVA  
3.33
-0.12 (-3.48%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)174.39M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.5 Million
Adjusted EPS-$0.52
See more estimates
10-Day MA$3.48
50-Day MA$3.68
200-Day MA$3.91
See more pivots

Inventiva - ADR Stock, NASDAQ:IVA

50, rue de Dijon, Daix, Bourgogne-Franche-Comte 21121
France
Phone: +33.3.80.44.75.00
Number of Employees: 123
http://www.inventivapharma.com

Description

Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Fr�©d�©ric Cren on October 27, 2011 and is headquartered in Daix, France.